Keith Veitch

922 total citations
28 papers, 750 citations indexed

About

Keith Veitch is a scholar working on Molecular Biology, Clinical Biochemistry and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Keith Veitch has authored 28 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 8 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Keith Veitch's work include Metabolism and Genetic Disorders (10 papers), Mitochondrial Function and Pathology (9 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Keith Veitch is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Mitochondrial Function and Pathology (9 papers) and Pharmacological Effects and Toxicity Studies (8 papers). Keith Veitch collaborates with scholars based in Belgium, France and Switzerland. Keith Veitch's co-authors include Sylvie Ponchaut, François Van Hoof, Louis Hue, L. Hue, H. Pouleur, C. Depre, Mark H. Rider, Jòseph Vamecq, Michael Bröker and Jean‐Pierre Draye and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and The American Journal of Cardiology.

In The Last Decade

Keith Veitch

28 papers receiving 724 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Veitch Belgium 17 366 163 126 119 110 28 750
F. Labarthe France 17 502 1.4× 274 1.7× 78 0.6× 33 0.3× 227 2.1× 61 1.0k
Klaus P. Kohse Germany 17 298 0.8× 50 0.3× 38 0.3× 35 0.3× 196 1.8× 40 797
Nathalie Petit France 15 576 1.6× 70 0.4× 52 0.4× 28 0.2× 96 0.9× 30 1.1k
Gilbert Reibnegger Austria 11 263 0.7× 144 0.9× 27 0.2× 22 0.2× 26 0.2× 15 833
Annick Thompson Switzerland 12 278 0.8× 118 0.7× 24 0.2× 73 0.6× 27 0.2× 13 751
Cameron G. McCarthy United States 13 299 0.8× 35 0.2× 62 0.5× 32 0.3× 130 1.2× 15 857
Jun Kido Japan 18 377 1.0× 452 2.8× 187 1.5× 25 0.2× 29 0.3× 82 1.2k
Maria Tassini Italy 14 191 0.5× 55 0.3× 52 0.4× 51 0.4× 42 0.4× 28 490
Christal G. Young United States 8 298 0.8× 54 0.3× 22 0.2× 58 0.5× 81 0.7× 10 705
Moritz von Frankenberg Germany 17 176 0.5× 32 0.2× 43 0.3× 186 1.6× 79 0.7× 40 1.0k

Countries citing papers authored by Keith Veitch

Since Specialization
Citations

This map shows the geographic impact of Keith Veitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Veitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Veitch more than expected).

Fields of papers citing papers by Keith Veitch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Veitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Veitch. The network helps show where Keith Veitch may publish in the future.

Co-authorship network of co-authors of Keith Veitch

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Veitch. A scholar is included among the top collaborators of Keith Veitch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Veitch. Keith Veitch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bröker, Michael & Keith Veitch. (2010). Quadrivalent meningococcal vaccines: Hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine. Travel Medicine and Infectious Disease. 8(1). 47–50. 20 indexed citations
2.
Bailleux, Fabrice, et al.. (2004). Aventis Pasteur Vaccines Containing Inactivated Hepatitis A Virus: A Compilation of Immunogenicity Data. European Journal of Clinical Microbiology & Infectious Diseases. 23(4). 300–309. 21 indexed citations
3.
Servat, Alexandre, et al.. (2003). Efficacy of rabies immunoglobulins in an experimental post-exposure prophylaxis rodent model. Vaccine. 22(2). 244–249. 12 indexed citations
4.
Denoël, Philippe, Jan Poolman, G. Carletti, & Keith Veitch. (2002). Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection. Vaccine. 20(19-20). 2551–2555. 17 indexed citations
5.
6.
Veitch, Keith & Louis Hue. (1994). Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism.. Molecular Pharmacology. 45(1). 158–163. 39 indexed citations
7.
Ponchaut, Sylvie & Keith Veitch. (1993). Valproate and mitochondria. Biochemical Pharmacology. 46(2). 199–204. 41 indexed citations
8.
Depre, C., Mark H. Rider, Keith Veitch, & Louis Hue. (1993). Role of fructose 2,6-bisphosphate in the control of heart glycolysis. Journal of Biological Chemistry. 268(18). 13274–13279. 64 indexed citations
9.
Ponchaut, Sylvie, François Van Hoof, & Keith Veitch. (1992). In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Biochemical Pharmacology. 43(11). 2435–2442. 90 indexed citations
10.
Ponchaut, Sylvie, François Van Hoof, & Keith Veitch. (1992). Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochemical Pharmacology. 43(3). 644–647. 37 indexed citations
11.
Veitch, Keith, et al.. (1992). Global ischaemia induces a biphasic response of the mitochondrial respiratory chain. Anoxic pre-perfusion protects against ischaemic damage. Biochemical Journal. 281(3). 709–715. 132 indexed citations
12.
Ponchaut, Sylvie, et al.. (1991). Influence of chronic administration of valproate on ultrastructure and enzyme content of peroxisomes in rat liver and kidney. Biochemical Pharmacology. 41(10). 1419–1428. 20 indexed citations
13.
Ponchaut, Sylvie, Jean‐Pierre Draye, François Van Hoof, & Keith Veitch. (1991). Loss of hepatic cytochrome aa3 during chronic valproate treatment: dissociation of proton pumping and electron transport in Complex IV. Biochemical Society Transactions. 19(3). 253S–253S. 3 indexed citations
14.
Veitch, Keith & François Van Hoof. (1990). In vitro effects of eight-carbon fatty acids on oxidations in rat liver mitochondria. Biochemical Pharmacology. 40(9). 2153–2159. 21 indexed citations
15.
Veitch, Keith, et al.. (1989). Altered acyl-CoA metabolism in riboflavin deficiency. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1006(3). 335–343. 33 indexed citations
16.
Draye, Jean‐Pierre, Keith Veitch, Jòseph Vamecq, & François Van Hoof. (1988). Comparison of the metabolism of dodecanedioic acid in vivo in control, riboflavin‐deficient and clofibrate‐treated rats. European Journal of Biochemistry. 178(1). 183–189. 26 indexed citations
17.
Veitch, Keith, et al.. (1988). Effects of riboflavin deficiency and clofibrate treatment on the five acyl-CoA dehydrogenases in rat liver mitochondria. Biochemical Journal. 254(2). 477–481. 13 indexed citations
18.
Hoof, François Van, Jòseph Vamecq, Jean‐Pierre Draye, & Keith Veitch. (1988). The catabolism of medium- and long-chain dicarboxylic acids. Biochemical Society Transactions. 16(3). 423–424. 4 indexed citations
19.
Veitch, Keith, et al.. (1987). The Effect of Riboflavin Deficiency On Mitochondrial and Peroxisomal Oxidations in Rat. Archives of Physiology and Biochemistry. 95(3). 1 indexed citations
20.
Veitch, Keith, et al.. (1987). The Effects of Sodium Valproate and Valproyl-coa On Rat-liver Mitochondrial Beta-oxidation. Archives of Physiology and Biochemistry. 95(3). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. Labarthe Breakdown of academic impact, for papers by Klaus P. Kohse Breakdown of academic impact, for papers by Nathalie Petit Breakdown of academic impact, for papers by Gilbert Reibnegger Breakdown of academic impact, for papers by Annick Thompson Breakdown of academic impact, for papers by Cameron G. McCarthy Breakdown of academic impact, for papers by Jun Kido Breakdown of academic impact, for papers by Maria Tassini Breakdown of academic impact, for papers by Christal G. Young Breakdown of academic impact, for papers by Moritz von Frankenberg
Rankless by CCL
2026